Wonderfeel Younger (Youngr NMN) review: is it worth it?

What is Wonderfeel Younger and who makes it?

Wonderfeel Younger, branded as Youngr NMN, is an oral dietary supplement in the longevity category. It is made by Wonderfeel, a U.S. company whose formula was developed by Andrew Salzman, MD, a Harvard-trained physician-scientist with a long background in drug discovery and NAD+ biology. That clinical pedigree is part of the brand's positioning, and it shows up in the formula: rather than selling NMN alone, Wonderfeel combines it with several supporting antioxidant and longevity-adjacent compounds.

Each bottle contains 60 capsules — a 30-day supply at the recommended two capsules daily. The per-serving formula is:

• NMN (β-nicotinamide mononucleotide): 900 mg (450 mg per capsule)
• Trans-resveratrol: 50 mg
• Ergothioneine: 2 mg
• Olive fruit extract (40% hydroxytyrosol): 25 mg
• Vitamin D3 (cholecalciferol): 10 mcg (400 IU)

The product is vegan, non-GMO, and free of soy, gluten, dairy and fish. It is sold direct-to-consumer rather than through a telehealth prescription, so no medical consultation is required.

One important regulatory note: NMN's status as a legal supplement ingredient has been turbulent. In late 2022 the FDA took the position that NMN was excluded from the definition of a dietary supplement because it had been authorized for investigation as a new drug (FDA). After a citizen petition and litigation from the Natural Products Association, the FDA reversed course in 2025 — formally communicated in fall 2025 — concluding that NMN "is not excluded from the definition of a dietary supplement" under the "race-to-market" provision, citing evidence that NMN was marketed as a supplement before being authorized for drug investigation (FDA; Venable LLP 2025). NMN is therefore lawfully sold in the U.S. today, but the episode is a reminder that this is a young, lightly regulated category.

How does NMN work?

NMN is a direct biochemical precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme present in every cell that is essential for energy metabolism, DNA repair, and the activity of "longevity" enzymes called sirtuins. NAD+ levels decline with age in many tissues, and a large body of *animal* research suggests that restoring NAD+ — for example by feeding mice NMN — can improve metabolic, vascular and muscular function.

The logic Wonderfeel and the rest of the category rely on is straightforward: if low NAD+ contributes to features of aging, raising it back up might slow or reverse some of them. The first step in that chain is well established. Multiple randomized human trials confirm that oral NMN reliably and dose-dependently raises blood NAD+ levels (PMID 36482258; Frontiers in Aging 2022). The second step — that raising NAD+ produces meaningful, durable health benefits in humans — is where the evidence is still thin.

The supporting ingredients are added to act on adjacent pathways. Resveratrol is a putative sirtuin activator, theoretically complementing NMN's role in feeding NAD+ into sirtuin-driven processes. Ergothioneine and hydroxytyrosol (from olive) are antioxidants with their own small bodies of research. Vitamin D3 is included for general health rather than NAD+ biology.

What does the evidence behind each ingredient show?

NMN (900 mg) — strong on NAD+, early on outcomes

NMN is the only ingredient here with a credible, growing base of human randomized trials, and they consistently show two things: it is safe and well tolerated at doses up to at least 900 mg/day, and it raises blood NAD+ (PMID 36482258).

The single most relevant trial for Wonderfeel is a randomized, multicenter, double-blind, placebo-controlled dose-finding study published in *GeroScience* in 2023 (Yi et al., PMID 36482258). It enrolled 80 healthy middle-aged adults (40–65) and tested 300, 600 and 900 mg/day over 60 days. All three doses significantly increased blood NAD+ versus placebo and improved six-minute walking distance, with the largest NAD+ and physical-performance effects in the 600 mg and 900 mg groups. Critically, the authors concluded that clinical efficacy "reaches highest at a dose of 600 mg daily," and that the 900 mg/day dose "did not give significantly better efficacy than 600 mg/day." That is worth underlining: Wonderfeel markets its 900 mg dose as backed by "the largest human trial," and it is — but that same trial suggests 600 mg captured most of the effect.

The other widely cited human study is Yoshino et al. 2021 in *Science* (PMID 33888596), which gave 250 mg/day NMN to postmenopausal women with prediabetes for 10 weeks and found improved skeletal-muscle insulin sensitivity. It is an important proof-of-concept, but small (about two dozen participants), and a published technical comment questioned the analysis and interpretation (Science 2021), so it should be read cautiously rather than as settled.

What the NMN literature does not yet show is the headline promise: longer lifespan, reversal of biological aging, or hard clinical endpoints (heart attacks, dementia, mortality). Those studies have not been done in humans. A systematic review and meta-analysis of NMN RCTs found that, while blood NAD+ rises reliably, short-term NMN supplementation (250–2000 mg/day) did not produce significant benefits on glucose control (fasting glucose, insulin, HbA1c, HOMA-IR) or lipid profile (Critical Reviews in Food Science and Nutrition, 2024).

Trans-resveratrol (50 mg)

Resveratrol is one of the most-studied "longevity" compounds, but human results have been underwhelming and inconsistent, and its oral bioavailability is poor. The 50 mg dose here is modest — many resveratrol trials use 150 mg to 1,000 mg or more. Its presence is mechanistically reasonable (sirtuin support) but should be viewed as a supporting actor with limited independent evidence, not a proven benefit.

Ergothioneine (2 mg)

Ergothioneine is a naturally occurring amino acid antioxidant found in mushrooms; some observational data associate higher blood levels with better cardiovascular and cognitive markers, though this is correlational and not proof of benefit. In any case, 2 mg is a small dose relative to dietary intake studies, so its real-world contribution in this formula is likely minor.

Hydroxytyrosol / olive fruit extract (25 mg standardized to 40%)

Hydroxytyrosol is the polyphenol behind much of olive oil's antioxidant reputation, and the EU's EFSA has recognized that olive oil polyphenols (including hydroxytyrosol) contribute to protecting blood lipids from oxidative stress — though the EFSA claim is specified for olive oil delivering at least 5 mg of hydroxytyrosol and derivatives per day, not for isolated extracts in supplements (EFSA). The dose here is reasonable for a general antioxidant role but is not a treatment dose for any specific condition.

Vitamin D3 (10 mcg / 400 IU)

A sensible general-health inclusion, though 400 IU is a maintenance-level dose, well below what someone who is genuinely deficient would be prescribed.

Does Wonderfeel Younger actually work?

Honestly assessed: it almost certainly raises your NAD+ levels, and it may produce small improvements in things like physical performance, especially in middle-aged or older adults whose NAD+ has declined. That is supported by human RCTs of NMN at these doses (PMID 36482258).

What it has not been shown to do — for NMN generally or for Wonderfeel specifically — is make you measurably "younger," extend lifespan, or reverse aging. The product name and category marketing imply more than the human evidence currently supports. There are also no published trials on Wonderfeel's *specific multi-ingredient formula*; the evidence is borrowed from single-ingredient NMN studies. Whether adding resveratrol, ergothioneine and hydroxytyrosol improves outcomes beyond NMN alone is unproven.

A second honest caveat: a higher blood NAD+ number is a biomarker, not a clinical outcome. It is encouraging, and biologically plausible, but it is not the same as proof that you will live longer or healthier. Anyone buying this should understand they are making an evidence-informed bet, not a sure thing.

Who is it best for, and who should skip it?

Potentially a reasonable choice for:

• Health-motivated adults, roughly 40+, who specifically want to raise NAD+ and accept that long-term benefits are unproven
• People who would otherwise buy a plain NMN product and value the added (if lightly dosed) antioxidants and a clinician-designed formula
• Those who prioritize third-party-tested, transparently labeled products in a category notorious for poor quality control

Should skip it (or check with a clinician first):

• Anyone pregnant or breastfeeding — NMN has not been studied in these groups
• People with active or prior cancer: NAD+ is used by all rapidly dividing cells, and the theoretical effect of boosting it in the context of cancer is unresolved, so caution is warranted (this is a genuine open question, not a settled risk)
• Anyone expecting a treatment for a diagnosed condition (diabetes, heart disease) — this is a supplement, not a therapy
• Budget-sensitive buyers who would get most of the measured benefit from cheaper, plain NMN at 300–600 mg

Side effects and safety

Across human trials, NMN has a reassuring short-term safety profile. The dose-finding trial reported that NMN was safe and well tolerated with oral dosing up to 900 mg/day over 60 days, with no significant adverse events or abnormal lab findings versus placebo (PMID 36482258); the 250 mg/day, 10-week study in postmenopausal women likewise reported no notable safety problems (PMID 33888596). Mild, infrequent reports across the NMN literature include nausea, indigestion, flushing, headache or fatigue.

The real limitation is duration and scale: most trials run weeks to a few months with dozens of participants. There is no long-term human safety data over years, which matters for a product intended for daily lifelong use. Resveratrol can interact with drugs metabolized by the CYP450 system and may have mild blood-thinning effects, so people on anticoagulants or multiple medications should consult a pharmacist or physician.

How to take it

The recommended dose is two capsules once daily in the morning (900 mg NMN total). Morning dosing is suggested to align with the body's natural NAD+ rhythm. There is no requirement to take it with food, though doing so may reduce the rare GI upset. Notably, the dose-finding evidence suggests 600 mg/day may be the efficiency "sweet spot" — so the extra 300 mg in Wonderfeel's serving may add cost without proportional benefit.

Cost and value

Wonderfeel Younger costs $88 for a 30-day supply as a one-time purchase, with a subscription option that saves about $15 per bottle (roughly $73/month) — about $2.43 to $2.93 per day. That is on the premium end. The price buys a clinician-designed, multi-ingredient, third-party-tested formula, which is a real differentiator in a category full of unverified NMN powder.

Value-wise, the honest framing is: you are paying a premium over plain NMN (which can be found at well under $1/day) for the supporting ingredients, formulation work, and quality assurance. Whether that premium is worth it depends on how much you value those things, because the *core* benefit — raising NAD+ — is delivered by NMN alone.

How it compares to alternatives

• Plain NMN (e.g., bulk or single-ingredient brands): Cheaper and delivers the same NAD+-raising mechanism. Wonderfeel's edge is formulation, dosing rationale, and testing — not a fundamentally different effect.
• NR (nicotinamide riboside, e.g., Tru Niagen): A different NAD+ precursor with arguably more total human safety data and clearer regulatory standing. NR vs NMN is genuinely unsettled; neither has proven superior for anti-aging outcomes in humans.
• Niacin / nicotinic acid: The cheapest NAD+ precursor by far, with decades of use, but causes flushing and is not marketed for longevity.
• NAD+ IV therapy: Far more expensive, invasive, and lacking strong evidence of advantage over oral precursors for most people.

The bottom line

Wonderfeel Younger is among the better-constructed NMN products available: a 900 mg NMN dose, a clinician-designed multi-ingredient formula, transparent labeling, and third-party testing in a category that badly needs it. It will very likely raise your NAD+ levels, and human trials at this dose show good short-term safety and modest improvements in measures like walking distance. But the anti-aging promise implied by the name outruns the evidence — there are no human studies on lifespan, biological aging reversal, or this exact formula, the supporting ingredients are lightly dosed, and dose-finding data suggest 600 mg of NMN captures most of the measurable benefit at lower cost. It is a defensible, premium choice for an informed adult who wants to bet on NAD+ science with eyes open — not a proven path to living longer.